Generation Bio Co.
NASDAQ Global SelectTotal Valuation
Generation Bio Co. carries a market capitalization of 35.98M, placing it among publicly traded companies globally. Its enterprise value stands at -22.49M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 35.98M |
| Enterprise Value | -22.49M |
Share Statistics
Generation Bio Co. currently has 6.74M shares outstanding.
| Shares Outstanding | 6.74M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 2.69, and the price-to-book ratio stands at -0.06.
| PE Ratio | N/A |
| PS Ratio | 2.69 |
| PB Ratio | -0.06 |
| P/TBV Ratio | 0.81 |
| P/FCF Ratio | -0.36 |
| P/OCF Ratio | -0.36 |
Financial Position
Generation Bio Co. maintains a current ratio of 4.44, meaning it holds 4.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.44 |
| Quick Ratio | 4.28 |
| Debt / Equity | 51.61 |
| Debt / EBITDA | -0.31 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -33.79 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Generation Bio Co.'s stock has gained approximately 1.71429% over the past 52 weeks. The 50-day moving average sits at 5.52, while the 200-day moving average is 5.11.
| Beta (5Y) | N/A |
| 52-Week Price Change | 1.71429% |
| 50-Day Moving Average | 5.52 |
| 200-Day Moving Average | 5.11 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Generation Bio Co. generated 15.27M in revenue and converted that into -62.63M in net income, yielding earnings per share of -9.34. EBITDA reached -85.18M, while operating income came in at -90.03M.
| Revenue | 15.27M |
| Gross Profit | N/A |
| Operating Income | -90.03M |
| Pretax Income | -62.63M |
| Net Income | -62.63M |
| EBITDA | -85.18M |
| EBIT | -90.03M |
| Earnings Per Share (EPS) | -9.34 |
Balance Sheet
Generation Bio Co. holds 89.62M in cash and equivalents against 26.10M in total debt, resulting in a net debt position of -21.94M. Total book value stands at -744.29M, with working capital of 72.42M providing operational flexibility.
| Cash & Cash Equivalents | 89.62M |
| Total Debt | 26.10M |
| Net Debt | -21.94M |
| Equity (Book Value) | -744.29M |
| Book Value Per Share | -111.01 |
| Working Capital | 72.42M |
Cash Flow
Generation Bio Co. produced -113.65M in operating cash flow over the past twelve months. After subtracting -1.08M in capital expenditures, free cash flow totaled -114.73M - equivalent to -17.11 per share.
| Operating Cash Flow | -113.65M |
| Capital Expenditures | -1.08M |
| Free Cash Flow | -114.73M |
| FCF Per Share | -17.11 |
Margins
Generation Bio Co. operates with a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of -589.59 and net profit margin of -410.13 provide insight into operational efficiency.
| Gross Margin | 100.00 |
| Operating Margin | -589.59 |
| Pretax Margin | -410.13 |
| Profit Margin | -410.13 |
| EBITDA Margin | -557.83 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -0.52 |
| FCF Yield | -274.34 |
Stock Splits
Generation Bio Co.'s most recent stock split took place on July 22, 2025 with a 10:1 split ratio.
| Last Split Date | 7/22/2025 |
| Split Ratio | 10:1 |
Scores
Generation Bio Co. posts an Altman Z-Score of -9.80, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -9.80 |